Pinaverium Bromide is a bromide salt of pinaverium, which is a calcium channel blocker (CCB) with antispasmodic properties. It is used in the treatment of irritable bowel syndrome and is most effective when used for the entire course of treatment and is not intended for short-term or intermittent use.
It is sold worldwide under the brand names Dicetel and Eldicet. The generic version is sold under the brand name Disten in South Korea and Nulite in Argentina.
|Name of Product||Pinaverium Bromide|
|Synonyms||Dicetel; Pinaverii bromidum; Bromuro de pinaverio; Bromure de pinaverium; pinaverium bromur|
|Molecular Weight||591.4 g/mol|
|1||Appearance (Form)||Solid Crystals or Powder|
|2||Appearance (Color)||White to Off-white to Slightly yellow|
|3||Solubility||Slightly soluble in DMSO and Methanol|
|4||Melting point||159.0 to 163.0 °C|
|5||Warnings||Hygroscopic & Heat Sensitive|
Pinaverium Bromide acts as a selective and specific voltage-dependent calcium channel blocker. By reducing inward calcium current and calcium inflow, it decreases smooth muscle contractions of the GI tract, thereby relaxing intestinal muscles and helps in relieving conditions such as cramps, pain, bloating, and discomfort.
The side effects associated with the use of Pinaverium Bromide are as follows-
Q. Is Pinaverium Bromide an over the counter drug?
Pinaverium Bromide is not an over the counter drug. It is only available on prescription from a medical practitioner.
Q. How long does it take for Pinaverium Bromide to work?
Pinaverium bromide is rapidly absorbed after being taken orally, with peak plasma concentrations occurring within an hour of taking the medication.
Q. Is Pinaverium Bromide taken before or after food?
The standard starting dose of pinaverium for adults is 50 mg, given three times day with a glass of water during meals or snacks.
Q. What is the combination of Pinaverium Bromide and Dimethicone used for?
Q. Where to buy Pinaverium Bromide?
Macsen Laboratories is the manufacturer and supplier of high-quality Pinaverium Bromide API.